Selected article for: "cc ND international license and herd immunity"
Author: Yasuhiko Kamikubo; Atsushi Takahashi
Title: Epidemiological Tools that Predict Partial Herd Immunity to SARS Coronavirus 2
  • Document date: 2020_3_27
    • ID: 7onenxg7_24
    Snippet: Quantitative analysis for SARS-CoV-2-specific IgM and IgG antibodies in the blood of healthy persons may reveal herd immunity against S type SARS-CoV-2. Such seroepidemiological data will predict the effectiveness and risk of herd immunity . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity......
    Document: Quantitative analysis for SARS-CoV-2-specific IgM and IgG antibodies in the blood of healthy persons may reveal herd immunity against S type SARS-CoV-2. Such seroepidemiological data will predict the effectiveness and risk of herd immunity . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and herd immunity: 1, 2, 3, 4, 5, 6, 7, 8
    • cc NC ND International license and IgG SARS IgM antibody: 1
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and quantitative analysis: 1
    • cc NC ND International license and type SARS: 1, 2, 3, 4, 5, 6, 7
    • healthy person and International license: 1
    • healthy person and risk effectiveness: 1
    • herd immunity and IgG SARS IgM antibody: 1
    • herd immunity and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • herd immunity and quantitative analysis: 1, 2, 3
    • herd immunity and risk effectiveness: 1, 2, 3
    • herd immunity and type SARS: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • IgG SARS IgM antibody and International license: 1, 2
    • IgG SARS IgM antibody and type SARS: 1
    • International license and quantitative analysis: 1, 2, 3, 4, 5, 6
    • International license and type SARS: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • quantitative analysis and risk effectiveness: 1
    • quantitative analysis and type SARS: 1, 2, 3, 4, 5, 6, 7